These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30416485)

  • 21. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
    Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM
    J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption.
    Marchi N; Fazio V; Cucullo L; Kight K; Masaryk T; Barnett G; Vogelbaum M; Kinter M; Rasmussen P; Mayberg MR; Janigro D
    J Neurosci; 2003 Mar; 23(5):1949-55. PubMed ID: 12629200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hyperosmotic solutions on human brain tumour vasculature.
    Sato S; Kawase T; Harada S; Takayama H; Suga S
    Acta Neurochir (Wien); 1998; 140(11):1135-41; disc 1141-2. PubMed ID: 9870058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Hyperosmolar Blood-Brain Barrier Opening in Glioblastoma via Histology with Evans Blue and DCE-MRI.
    Conq J; Joudiou N; Ucakar B; Vanvarenberg K; Préat V; Gallez B
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo imaging of sterile microglial activation in rat brain after disrupting the blood-brain barrier with pulsed focused ultrasound: [18F]DPA-714 PET study.
    Sinharay S; Tu TW; Kovacs ZI; Schreiber-Stainthorp W; Sundby M; Zhang X; Papadakis GZ; Reid WC; Frank JA; Hammoud DA
    J Neuroinflammation; 2019 Jul; 16(1):155. PubMed ID: 31345243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of various methods for delivering radiolabeled monoclonal antibody to normal rat brain.
    Bullard DE; Bourdon M; Bigner DD
    J Neurosurg; 1984 Nov; 61(5):901-11. PubMed ID: 6436447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time monitoring of human blood-brain barrier disruption.
    Kiviniemi V; Korhonen V; Kortelainen J; Rytky S; Keinänen T; Tuovinen T; Isokangas M; Sonkajärvi E; Siniluoto T; Nikkinen J; Alahuhta S; Tervonen O; Turpeenniemi-Hujanen T; Myllylä T; Kuittinen O; Voipio J
    PLoS One; 2017; 12(3):e0174072. PubMed ID: 28319185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-arterial infusions of drugs and hyperosmotic solutions as ways of enhancing CNS chemotherapy.
    Fenstermacher J; Gazendam J
    Cancer Treat Rep; 1981; 65 Suppl 2():27-37. PubMed ID: 7346144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect on the tumor vessel permeability by hyperosmotic blood brain barrier disruption].
    Miyagami M; Tazoe M; Kagawa Y; Tsubokawa T
    No To Shinkei; 1988 Sep; 40(9):875-82. PubMed ID: 3142506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits.
    Wang M; Etu J; Joshi S
    J Neurosurg Anesthesiol; 2007 Oct; 19(4):249-56. PubMed ID: 17893577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82.
    Zünkeler B; Carson RE; Olson J; Blasberg RG; Girton M; Bacher J; Herscovitch P; Oldfield EH
    J Neurosurg; 1996 Mar; 84(3):494-502. PubMed ID: 8609564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate.
    Preston E; Slinn J; Vinokourov I; Stanimirovic D
    J Neurosci Methods; 2008 Mar; 168(2):443-9. PubMed ID: 18155299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of barrier opening on brain edema in human brain tumors.
    Sato S; Suga S; Yunoki K; Mihara B
    Acta Neurochir Suppl (Wien); 1994; 60():116-8. PubMed ID: 7976519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.
    Kroll RA; Neuwelt EA
    Neurosurgery; 1998 May; 42(5):1083-99; discussion 1099-100. PubMed ID: 9588554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment.
    Rodriguez A; Tatter SB; Debinski W
    Pharmaceutics; 2015 Aug; 7(3):175-87. PubMed ID: 26247958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperosmotic blood-brain barrier disruption in brains of rats with an intracerebrally transplanted RG-C6 tumor.
    Inoue T; Fukui M; Nishio S; Kitamura K; Nagara H
    J Neurosurg; 1987 Feb; 66(2):256-63. PubMed ID: 3100731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood-Brain Barrier Disruption.
    Pinkiewicz M; Pinkiewicz M; Walecki J; Zaczyński A; Zawadzki M
    Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-Level Laser Treatment Induces the Blood-Brain Barrier Opening and the Brain Drainage System Activation: Delivery of Liposomes into Mouse Glioblastoma.
    Semyachkina-Glushkovskaya O; Bragin D; Bragina O; Socolovski S; Shirokov A; Fedosov I; Ageev V; Blokhina I; Dubrovsky A; Telnova V; Terskov A; Khorovodov A; Elovenko D; Evsukova A; Zhoy M; Agranovich I; Vodovozova E; Alekseeva A; Kurths J; Rafailov E
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery.
    Muldoon LL; Pagel MA; Kroll RA; Roman-Goldstein S; Jones RS; Neuwelt EA
    AJNR Am J Neuroradiol; 1999 Feb; 20(2):217-22. PubMed ID: 10094341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors.
    Sajesh BV; On NH; Omar R; Alrushaid S; Kopec BM; Wang WG; Sun HD; Lillico R; Lakowski TM; Siahaan TJ; Davies NM; Puno PT; Vanan MI; Miller DW
    Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31533285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.